In specific, genus Anaerotruncus was reported related to hypertension [61,62,63], diabetes mellitus [64], and dipeptidyl peptidase 4 inhibitors used [65], which were unbalance in the pre-matched cohort. This evidence concerns the gene DPP4 and hypertensive disorder.